Ansh Enterprises

Bdron 250mg Tablet contains the active constituent abiraterone acetate. It is used in adult men to treat prostate cancer, which has spread to other parts of the body. It is usually given with steroid medication to lower the chances of side effects. When Bdron 250mg Tablet is prescribed for an early stage of this disorder, it is used with testosterone lowering treatment. This medicine is not for use in women or children. Effective contraception must be taken throughout the treatment. This medicine contains lactose and sodium, inform your physician if you have lactose intolerance or on a salt control diet.

Inform to the physician if the patients have liver problems, high blood pressure, heart disorders, low blood potassium, diabetes, allergic conditions, or other diseases. Make sure to inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start the treatment with this medication. The most common side effects of this medication are fluid in feet or legs, high blood pressure, and diarrhea. A decrease in red blood cells and reduced sex drive may also occur with the intake of Bdron 250mg Tablet. This medicine should not be taken with Ra-223, which is used to treat prostate cancer. 

Chemogef 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

A drug used to treat thrombocytopenia (a low blood platelet count) in adults and children with chronic immune thrombocytopenic purpura that did not get better with other treatment. Eltrombopag olamine is also used to treat severe aplastic anemia.

ErlotiRel (Erlotinib), a kinase inhibitor, is a quinazolinamine with the chemical name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine. Erlotinib inhibits the intracellular phosphorylation of tyrosine kinase associated with the epidermal growth factor receptor (EGFR).

Erlotinib has been approved by FDA for maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. It is also approved for the treatment of locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen and is a first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine. Erlotinib is also approved by EMEA for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations.

ErlotiRel (Erlotinib) tablets for oral administration are available in dosage strengths equivalent to 25 mg, 100 mg and 150 mg Erlotinib.

ErlotiRel (Erlotinib), a kinase inhibitor, is a quinazolinamine with the chemical name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine. Erlotinib inhibits the intracellular phosphorylation of tyrosine kinase associated with the epidermal growth factor receptor (EGFR).

Erlotinib has been approved by FDA for maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. It is also approved for the treatment of locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen and is a first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine. Erlotinib is also approved by EMEA for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations.

ErlotiRel (Erlotinib) tablets for oral administration are available in dosage strengths equivalent to 25 mg, 100 mg and 150 mg Erlotinib.

Laviat 25 mg Capsule is used to treat multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma. Laviat 25 mg Capsule is used to treat a type of myelodysplastic syndromes (MDS) known as deletion 5q MDS, where part of chromosome 5 is missing. Laviat 25 mg Capsule contains ‘lenalidomide’, which works by helping the body’s immune system and directly attacks cancer. It stops the development of cancer cells, stops the blood vessels growing in cancer, and stimulates the part of the immune system to attack the cancer cells. Laviat 25 mg Capsule kills the abnormal cells in the bone marrow and helps the bone marrow to produce normal blood cells. You are advised to take Laviat 25 mg Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects, such as fatigue, constipation, diarrhoea, muscle cramps, nausea, headache, upper respiratory tract infection, dizziness, shortness of breath, and weakness. Talk with your doctor if you experience any of these side effects persistently. Avoid taking Laviat 25 mg Capsule if you are pregnant or breastfeeding. Laviat 25 mg Capsule may cause dizziness, sleepiness, tiredness, and blurred vision, so drive only if you are alert. Laviat 25 mg Capsule is not recommended for children below 18 years as safety and effectiveness have not been established. Men and women taking Laviat 25 mg Capsule must use effective contraception. Inform your doctor regarding your health condition and medications before taking Laviat 25 mg Capsule to rule out any interactions.

Natclovir- Ganciclovir 500mg is compelling in the event that utilized in the portion and term exhorted by your primary care physician. Try not to quit taking it regardless of whether you see improvement in your condition. On the off chance that you quit utilizing Natclovir 500mg Infusion too soon, the side effects might return or decline.

How is Natclovir- Ganciclovir 500mg Injection managed?

Natclovir 500mg Infusion ought to be directed under the oversight of a prepared medical services proficient or a specialist just and ought not be self-regulated. The portion will rely upon the condition you are being treated for and will be chosen by your PCP. Adhere to your doctor’s directions cautiously to get most extreme advantage from Natclovir 500mg Infusion.